Learn bits
Health & Medicine
Mahesh

12/05/24 19:50 PM IST

Pharma Sector in India

In News
  • India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has withdrawn powers delegated to State licensing authorities to issue NOCs (no objection certificates) for manufacture of unapproved, banned or new drugs for export purposes.
Role in Pharma market
  • India ranks third worldwide as a producer of drugs and pharmaceuticals by volume, exporting to around 200 countries/territories.
  • The Indian pharmaceutical industry supplies 62% of the global demand for vaccines and is a leading supplier of DPT (diphtheria, pertussis and tetanus), BCG (Bacillus Calmette-Guérin, used primarily against tuberculosis), and measles vaccines.
Impact
  • India is a key player in the international generic medicine market and any change in policy has a direct impact on manufacturers and importers, say industry insiders.
  • The centralising of the licensing authority is significant, they point out, because according to a study conducted by the Department of Pharmaceuticals, India needs to get ready to take advantage of drug sales worth $251 billion going off-patent this coming decade.
  • The study notes: “In the years between 2022 and 2030, the pharmaceutical sector in India will undergo landmark changes as several drugs are expected to go off-patent and provide an opportunity for the entry of generic products.
  • Expiry of patents is very promising for the Indian generic drug market as it is expected to expand and grow further with inclusion of these new drugs. With ongoing developments, India has started focusing on self-reliance at a large scale.
  • Hence, it is imperative to identify these drugs beforehand, draft and implement strategies which help in their timely entry into the market by promoting generic drug manufacturing.”
Challenges
  • India is dealing with several challenges, including tackling intellectual property rights, lack of research and development etc.
  • The study points out that understanding the political, economic, sociocultural, technological, environmental, and legal factors is vital for assessing the opportunities and challenges in the pharmaceutical market in India.
  • “The industry must adapt to changes in these external factors, navigate regulatory requirements, leverage technology advancements, and align their strategies with the evolving needs of the pharmaceutical industry to succeed in the global market.
  • This will result in the efficiency of the overall process along with bolstering pharma exports to key international markets. It will help to bring uniformity in protocols, achieve the target of reaching $450 billion by 2047.
Quality of Manufacturing
  • Indian government cracks down on 18 drug companies for poor quality manufacturing’, noted that the Indian government had cancelled the licences of over 10 pharmaceutical companies as part of a crackdown on poor quality manufacturing.
  • The action last March came after an inspection of 76 drug firms across 20 States.
  • The government is also understood to have given notices to a further 26 companies for not complying with good manufacturing processes.
  • The Indian pharmaceutical industry has an estimated 10,500 companies, with drug exports having more than doubled in the past decade.
  • But the industry has faced a series of scandals of late, including a World Health Organization investigation into four contaminated cough syrups that caused acute kidney injuries and were linked to the deaths of 66 children in the Republic of the Gambia last year.
Way forward
  • The centralisation of powers hasn’t come as an overnight development, says an industry expert.
  • The Central government’s advisory group on drugs had earlier this year noted that getting NOCs from local drug regulators for pharmaceutical products is a tedious process, leading to delays.
  •  Also, the central authority was always the Central government; the power to hand out licences for export of drugs was delegated to States a few years ago.
Source- The Hindu

More Related Current Affairs View All

21 Sep

India Achieves Tier 1 Status in Global Cybersecurity Index 2024

' India has secured Tier 1 status in the Global Cybersecurity Index (GCI) 2024, published by the International Telecommunication Union (ITU).' The GCI is a comprehensive assessm

Read More

21 Sep

A new White Revolution

'Operation Flood, launched in 1970, ushered in the White Revolution and transformed the dairy sector in India.' Dairy cooperatives procured 660 lakh kg of milk per day in 2023-2

Read More

21 Sep

Changes in Canada’s international work permit system

'Canadian Prime Minister Justin Trudeau announced changes to the country’s international work permit system, aiming to reduce the number of immigrant workers in Canada.'

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps